Magnetic resonance imaging safety in pacemaker and implantable cardioverter defibrillator patients: How far have we come?

European Heart Journal

Volumn 36, Issue 24, 2015, Pages 1505-1511

  Nordbeck, Peter ^a   Ertl, Georg ^a   Ritter, Oliver ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Cardiac pacemaker; Cardiovascular magnetic resonance imaging; ICD; Implantable cardioverter defibrillator; MRI conditional devices; MRI safety

Indexed keywords

CARDIOVASCULAR MAGNETIC RESONANCE; ELECTROCARDIOGRAPHY; HEALTH CARE QUALITY; HEATING; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAGNETIC FIELD; NUCLEAR MAGNETIC RESONANCE SCANNER; PACEMAKER; PACEMAKER IMPLANTATION; PATIENT MONITORING; PATIENT RISK; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION SAFETY; REVIEW; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL (TOPIC); CONTRAINDICATIONS; ELECTROMAGNETISM; HEAT; MAGNETIC RESONANCE ANGIOGRAPHY; PATIENT SAFETY; PROSTHESIS DESIGN; RISK FACTOR;

CLINICAL TRIALS AS TOPIC; DEFIBRILLATORS, IMPLANTABLE; ELECTROMAGNETIC FIELDS; HOT TEMPERATURE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; PACEMAKER, ARTIFICIAL; PATIENT SAFETY; PROSTHESIS DESIGN; RISK FACTORS;

EID: 84940190610     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv086     Document Type: Review

References (64)

1. Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, Friedrich MG, Ho VB, Jerosch-Herold M, Kramer CM, Manning WJ, Patel M, Pohost GM, Stillman AE, White RD, Woodard PK. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: A report of the American college of cardiology foundation task forceon expert consensus documents. J Am Coll Cardiol 2010;55:2614-2662.
2. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. PACE 2005;28:326-328.
3. Bartsch C, Irnich W, Risse M, Weiler G. Unexpected sudden death of pacemaker patients during or shortly after magnetic resonance imaging [MRI]. XIX Congress of International Academy of Legal Medicine 2003.
4. IrnichW, Irnich B, Bartsch C, Stertmann WA, Gufler H, Weiler G.Doweneed pacemakers resistant to magnetic resonance imaging? Europace 2005;7:353-365.
5. Alagona P Jr, Toole JC, Maniscalco BS, Glover MU, Abernathy GT, Prida XE. Nuclear magnetic resonance imaging in a patient with aDDDpacemaker. PACE 1989;12:619.
6. Inbar S, Larson J, Burt T, Mafee M, Ezri MD. Case report: nuclear magnetic resonance imaging in a patient with a pacemaker. Am J Med Sci 1993;305:174-175.
7. Garcia-Bolao I, Albaladejo V, Benito A, Alegria E, Zubieta JL. Magnetic resonance imaging in a patient with a dual-chamber pacemaker. Acta Cardiologica. 1998;53: 33-35.
8. Fontaine JM, Mohamed FB, Gottlieb C, Callans DJ, Marchlinski FE. Rapid ventricular pacing in a pacemaker patient undergoing magnetic resonance imaging. PACE 1998; 21:1336-1339.
9. Achenbach S, MoshageW, Diem B, Bieberle T, Schibgilla V, Bachmann K. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes.Am Heart J 1997; 134:467-473.
10. Luechinger R, Zeijlemaker VA, Pedersen EM, Mortensen P, Falk E, Duru F, Candinas R, Boesiger P. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J. 2005;26:376-383.
11. Henderson JM, Tkach J, Phillips M, Baker K, Shellock FG, Rezai AR. Permanent neurological deficit related to magnetic resonance imaging in a patient with implanted deep brain stimulation electrodes for Parkinson's disease: case report. Neurosurgery. 2005; 57:E1063.
12. Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-tesla. J Am Coll Cardiol 2004;43: 1315-1324.
13. Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A, Meyer C, Strach K, Skowatsch D, Vahlhaus C, Litt H, Schild H. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: A prospective study with 115 examinations. Circulation 2006;114:1285-1292.
14. Fiek M, Remp T, Reithmann C, Steinbeck G. Complete loss of ICD programmability after magnetic resonance imaging. PACE 2004;27:1002-1004.
15. Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E, Manning WJ, Martin ET, Smith JM, Wilke N, Shellock FS. Safety of magnetic resonance imaging in patients with cardiovascular devices: An American heart association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: Endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007;116:2878-2891.
16. Irnich W. Risks to pacemaker patients undergoing magnetic resonance imaging examinations. Europace 2010;12:918-920.
17. Shellock FG, Tkach JA, Ruggieri PM, Masaryk TJ. Cardiac pacemakers, ICDs, and loop recorder: Evaluation of translational attraction using conventional ('long-bore') and 'short-bore' 1.5- And 3.0-tesla MR systems. J Cardiovasc MR 2003;5:387-397.
18. Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R. Force and torque effects of a 1.5-tesla MRI scanner on cardiac pacemakers and ICDs. PACE 2001;24: 199-205.
19. Roguin A, Schwitter J, Vahlhaus C, Lombardi M, Brugada J, Vardas P, Auricchio A, Priori S, Sommer T. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008;10:336-346.
20. Babouri A, Hedjeidj A. In vitro investigation of eddy current effect on pacemaker operation generated by low frequency magnetic field. IEEE Eng Med Biol Soc Annu Conf 2007;2007:5684-5687.
21. Nordbeck P, Weiss I, Ehses P, Ritter O, Warmuth M, Fidler F, Herold V, Jakob PM, Ladd ME, Quick HH, Bauer WR. Measuring RF-induced currents inside implants: impact of device configuration on MRI safety of cardiac pacemaker leads. Magn Reson Med. 2009;61:570-578.
22. Nyenhuis J, Park SM, Kamondetdacha R, Amjad A, Shellock F, Rezai A. MRI and implanted medical devices: basic interactions with an emphasis on heating. IEEE Trans Device Mater Reliab. 2005;5:467-480.
23. Tandri H, Zviman MM, Wedan SR, Lloyd T, Berger RD, Halperin H. Determinants of gradient field-induced current in a pacemaker lead system in a magnetic resonance imaging environment. Heart Rhythm 2008;5:462-468.
24. Nordbeck P, Fidler F, Weiss I, Warmuth M, Friedrich MT, Ehses P, Geistert W, Ritter O, Jakob PM, Ladd ME, Quick HH, Bauer WR. Spatial distribution of RF-induced e-fields and implant heating in MRI. Magn Reson Med 2008;60:312-319.
25. Calcagnini G, Triventi M, Censi F, Mattei E, Bartolini P, Kainz W, Bassen HI. In vitro investigation of pacemaker lead heating induced by magnetic resonance imaging: role of implant geometry. JMRI 2008;28:879-886.
26. Mattei E, Triventi M, Calcagnini G, Censi F, Kainz W, Mendoza G, Bassen HI, Bartolini P. Complexity of MRI induced heating on metallic leads: Experimental measurements of 374 configurations. Biomed Eng Online. 2008;7:11.
27. Park SM, Kamondetdacha R, Nyenhuis JA. Calculation of MRI-induced heating of an implanted medical lead wire with an electric field transfer function. JMRI 2007;26: 1278-1285.
28. Nordbeck P, Fidler F, Friedrich MT, Weiss I, Warmuth M, Gensler D, Herold V, GeistertW, Jakob PM, Ertl G, Ritter O, Ladd ME, Bauer WR, Quick HH. Reducing RF-related heating of cardiac pacemaker leads in MRI: implementation and experimental verification of practical design changes. Magn Reson Med 2012;68: 1963-1972.
29. Langman DA, Goldberg IB, Finn JP, Ennis DB. Pacemaker lead tip heating in abandoned and pacemaker-attached leads at 1.5 tesla MRI. JMRI 2011;33:426-431.
30. Nordbeck P, Ritter O, Weiss I, Warmuth M, Gensler D, Burkard N, Herold V, Jakob PM, Ertl G, Ladd ME, Quick HH, Bauer WR. Impact of imaging landmark on the risk of MRI-related heating near implanted medical devices like cardiac pacemaker leads. Magn Reson Med 2011;65:44-50.
31. Fisher JD. MRI: safety in patients with pacemakers or defibrillators: is it prime time yet? PACE 2005;28:263.
32. Levine PA. Industry viewpoint: St. Jude medical: pacemakers, ICDs and MRI. PACE 2005;28:266-267.
33. Stanton MS. Industry viewpoint: Medtronic: pacemakers, ICDs, and MRI. PACE 2005; 28:265.
34. Smith JM. Industry viewpoint: Guidant: pacemakers, ICDs, and MRI. PACE 2005;28: 264.
35. Gimbel JR, Johnson D, Levine PA, Wilkoff BL. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. PACE 1996;19: 913-919.
36. Sommer T, Lauck G, Schimpf R, von Smekal A, Wolke S, Block W, Gieseke J, Schneider C, Funke HD, Schild H. MRI in patients with cardiac pacemakers: in vitro and in vivo evaluation at 0.5 tesla. RoFo 1998;168:36-43.
37. Sommer T, Vahlhaus C, Lauck G, von Smekal A, Reinke M, Hofer U, Block W, Traber F, Schneider C, Gieseke J, Jung W, Schild H. MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 t. Radiology. 2000;215:869-879.
38. Vahlhaus C, Sommer T, Lewalter T, Schimpf R, Schumacher B, Jung W, Luderitz B. Interference with cardiac pacemakers by magnetic resonance imaging: Are there irreversible changes at 0.5 tesla? PACE 2001;24:489-495.
39. Strach K, Naehle CP, Muhlsteffen A, Hinz M, Bernstein A, Thomas D, Linhart M, Meyer C, Bitaraf S, Schild H, Sommer T. Low-field magnetic resonance imaging: increased safety for pacemaker patients? Europace. 2010;12:952-960.
40. Gimbel JR, Bailey SM, Tchou PJ, Ruggieri PM, Wilkoff BL. Strategies for the safe magnetic resonance imaging of pacemaker-dependent patients. PACE 2005;28: 1041-1046.
41. Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, Weiss RG, Berger RD, Bluemke DA, Halperin HR. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 2006;114:1277-1284.
42. Mollerus M, Albin G, Lipinski M, Lucca J. Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing a MRI scan. PACE 2008;31:1241-1245.
43. Naehle CP, Zeijlemaker V, Thomas D, Meyer C, Strach K, Fimmers R, Schild H, Sommer T. Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 tesla. PACE 2009;32:1526-1535.
44. Mollerus M, Albin G, Lipinski M, Lucca J. Ectopy in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing a MRI scan. PACE 2009;32:772-778.
45. Mollerus ME, Albin G, Lipinski M, Lucca J. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace 2010;12:947-951.
46. Halshtok O, Goitein O, Abu Sham'a R, Granit H, Glikson M, Konen E. Pacemakers and magnetic resonance imaging: no longer an absolute contraindication when scanned correctly. IMAJ 2010;12:391-395.
47. Burke PT, Ghanbari H, Alexander PB, Shaw MK, Daccarett M, Machado C. A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI). J Interv Card Electrophysiol 2010;28:59-66.
48. Buendia F, Sanchez-Gomez JM, Sancho-Tello MJ, Olague J, Osca J, Cano O, Arnau MA, Igual B. Nuclear magnetic resonance imaging in patients with cardiac pacing devices. Revista Espanola de Cardiologia 2010;63:735-739.
49. Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo AC, Caffo BS, Frick KD, Kraut MA, Kamel IR, Calkins H, Berger RD, Bluemke DA, Halperin HR. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. An Int Med 2011;155:415-424.
50. Cohen JD, Costa HS, Russo RJ. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators. Am J Cardiol 2012;110:1631-1636.
51. Boilson BA, Wokhlu A, Acker NG, Felmlee JP, Watson RE Jr, Julsrud PR, Friedman PA, Cha YM, Rea RF, Hayes DL, Shen WK. Safety of magnetic resonance imaging in patients with permanent pacemakers: A collaborative clinical approach. J Intervent Card Electrophysiol 2012;33:59-67.
52. Del Ojo JL, Moya F, Villalba J, Sanz O, Pavon R, Garcia D, Pastor L. Is magnetic resonance imaging safe in cardiac pacemaker recipients? PACE 2005;28:274-278.
53. Naehle CP, Meyer C, Thomas D, Remerie S, Krautmacher C, Litt H, Luechinger R, Fimmers R, Schild H, Sommer T. Safety of brain 3-tMRimaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology 2008;249:991-1001.
54. Gimbel JR. Magnetic resonance imaging of implantable cardiac rhythm devices at 3.0 tesla. PACE 2008;31:795-801.
55. Coman JA, Sandler DA, Thomas JR. Implantable cardiac defibrillator interactions with magnetic resonance imaging at 1, 5 tesla. Am Heart Assoc 2004;43:138A.
56. Naehle CP, Strach K, Thomas D, Meyer C, Linhart M, Bitaraf S, Litt H, Schwab JO, Schild H, Sommer T. Magnetic resonance imaging at 1.5-t in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2009;54:549-555.
57. Pulver AF, Puchalski MD, Bradley DJ, Minich LL, Su JT, Saarel EV, Whitaker P, Etheridge SP. Safety and imaging quality of MRI in pediatric and adult congenital heart disease patients with pacemakers. PACE 2009;32:450-456.
58. Gimbel JR, Kanal E, Schwartz KM, Wilkoff BL. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). PACE 2005;28:270-273.
59. Naehle CP, Kreuz J, Strach K, Schwab JO, Pingel S, Luechinger R, Fimmers R, Schild H, Thomas D. Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 t. Am Heart J 2011;161:1096-1105.
60. Mesubi O, Ahmad G, Jeudy J, Jimenez A, Kuk R, Saliaris A, See V, Shorofsky S, Dickfeld T. Impact of icd artifact burden on late gadolinium enhancement cardiac MR imaging in patients undergoing ventricular tachycardia ablation. PACE 2014;37: 1274-1283.
61. van der Graaf AW, Bhagirath P, Gotte MJ. MRI and cardiac implantable electronic devices: current status and required safety conditions. Netherlands Heart J 2014; 22:269-276.
62. Gray RW, Bibens WT, Shellock FG. Simple design changes to wires to substantially reduce MRI-induced heating at 1.5 t: implications for implanted leads. Magn Reson Imaging 2005;23:887-891.
63. Wilkoff BL, Bello D, Taborsky M, Vymazal J, Kanal E, Heuer H, Hecking K, Johnson WB, Young W, Ramza B, Akhtar N, Kuepper B, Hunold P, Luechinger R, Puererfellner H, Duru F, Gotte MJ, Sutton R, Sommer T. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm 2011;8:65-73.
64. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Blomstrom-Lundqvist C, Badano LP, Aliyev F, Bansch D, Bsata W, Buser P, Charron P, Daubert JC, Dobreanu D, Faerestrand S, Le Heuzey JY, Mavrakis H, McDonagh T, Merino JL, Nawar MM, Nielsen JC, Pieske B, Poposka L, Ruschitzka F, Van Gelder IC, Wilson CM. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: The task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013;34:2281-2329.